This report provides a comprehensive analysis of the global phage therapy kits market, projecting significant growth from 2025 through 2032. Driven by the escalating crisis of antibiotic resistance, the market is expanding across medical, food, and agricultural applications. Key growth drivers include advancements in phage engineering, increasing regulatory acceptance, and the rise of personalized phage cocktails. The study offers detailed segmentation by type, application, and geography, while evaluating competitive landscapes and strategic industry trends.

Market Overview

The global Phage Therapy Kits market is projected to experience significant growth, increasing from US$ 46.72 million in 2025 to US$ 131 million in 2032. This expansion represents a compound annual growth rate (CAGR) of 16.2% from 2026 to 2032.

Definition: Phage Therapy Kits refer to the use of bacteriophages—viruses that target and destroy specific bacterial strains—for the treatment of bacterial infections. These kits typically contain a selection of phages designed to treat infections that have developed resistance to traditional antibiotics.

Market Context: Phage therapy, involving the therapeutic use of bacteriophages to infect bacteria, is a promising field with significant potential to address the growing global challenge of antibiotic resistance. Consequently, the market for these kits is expected to undergo substantial growth in the coming years.

Key Market Trends

Several critical trends are expected to shape the future of the phage therapy kits market:

1. Increasing Prevalence of Antibiotic Resistance

• Rising Antibiotic Resistance: The overuse and misuse of antibiotics have resulted in a global increase in antibiotic-resistant bacteria, rendering traditional treatments less effective and driving demand for alternative solutions like phage therapy.
• Expanded Applications: Research is expanding the use of phage therapy to a wide range of infections, including respiratory, urinary tract, and skin infections. As clinical trials demonstrate efficacy, the market is expected to expand.

2. Advancements in Phage Research and Development

• Improved Phage Identification and Characterization: Technological advancements are enabling faster, more accurate identification and characterization of phages, facilitating the development of more targeted and effective kits.
• Enhanced Phage Engineering: Researchers are exploring methods to engineer phages to improve therapeutic properties, such as broadening host range, increasing stability, and enhancing the ability to overcome bacterial defenses.

3. Growing Regulatory Acceptance

• Regulatory Approvals: As regulatory bodies gain experience with phage therapy, an increase in product approvals is expected, providing greater market access and boosting investor confidence.
• International Collaboration: Global cooperation and the harmonization of regulatory frameworks will facilitate the development and commercialization of kits across various regions.

4. Increased Investment and Industry Interest

• Venture Capital and Pharmaceutical Investments: The potential to address the antibiotic resistance crisis has attracted significant investment from pharmaceutical companies and venture capital firms, driving innovation and accelerating development.
• Partnerships and Collaborations: Strategic partnerships between biotechnology companies, research organizations, and academic institutions will foster collaboration and accelerate the translation of research into commercial products.

5. Personalized Phage Therapy

• Tailored Phage Cocktails: Advancements in personalized medicine and genomics will enable the development of customized phage cocktails specifically tailored to individual patients and their unique infections.
• Precision Phage Therapy: This approach aims to improve treatment outcomes while reducing the risk of adverse effects.

Summary Outlook: The future market is poised for significant growth driven by antibiotic resistance, R&D advancements, regulatory progress, investment, and personalization. As the field evolves, a wider range of products will become available, offering new hope for treating antibiotic-resistant infections.

Report Scope and Methodology

Produced by LP Information, Inc. (LPI), the “Phage Therapy Kits Industry Forecast” provides a comprehensive analysis of the global landscape.

Research Capabilities:

• Historical and Forecast Data: The report reviews total world Phage Therapy Kits sales in 2025 and provides a comprehensive analysis of projected sales from 2026 through 2032, broken down by region, market sector, and sub-sector (in US$ millions).
• Comprehensive Analysis: The insight report highlights key trends related to revenue, market share, company formation, latest developments, and M&A activity.
• Competitive Intelligence: It analyzes the strategies of leading global companies, focusing on their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Market Segmentation Analysis: The report evaluates key trends, drivers, and affecting factors, breaking down the forecast by Type, Application, geography, and market size to identify emerging opportunities.
• Methodology: The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry.

Market Segmentation

By Type

• Medical Grade
• Laboratory Grade

By Application

• Medical
• Food Industry
• Agriculture
• Others

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of their market penetration, product portfolio, and coverage:

• BiomX
• PhagePro
• PhagoMed Biopharma
• MYRIADE
• DotBio
• Wuhan Greinon Biotechnology
• PhagePharm
• iNtRON Biotechnology
• Snipr Technologies
• CJ
• Phico Therapeutics

Key Questions Addressed

• What is the 10-year outlook for the global Phage Therapy Kits market?
• What factors are driving Phage Therapy Kits market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Phage Therapy Kits market opportunities vary by end market size?
• How does Phage Therapy Kits break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Phage Therapy Kits Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Phage Therapy Kits by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Phage Therapy Kits by Country/Region, 2021, 2025 & 2032

  • 2.2 Phage Therapy Kits Segment by Type

    • 2.2.1 Medical Grade

    • 2.2.2 Laboratory Grade

    • 2.2.3 Phage Therapy Kits Sales by Type

      • 2.2.3.1 Global Phage Therapy Kits Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Phage Therapy Kits Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Phage Therapy Kits Sale Price by Type (2021-2026)

  • 2.3 Phage Therapy Kits Segment by Application

    • 2.3.1 Medical

    • 2.3.2 Food Industry

    • 2.3.3 Agriculture

    • 2.3.4 Others

    • 2.3.5 Phage Therapy Kits Sales by Application

      • 2.3.5.1 Global Phage Therapy Kits Sale Market Share by Application (2021-2026)
      • 2.3.5.2 Global Phage Therapy Kits Revenue and Market Share by Application (2021-2026)
      • 2.3.5.3 Global Phage Therapy Kits Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Phage Therapy Kits Breakdown Data by Company

    • 3.1.1 Global Phage Therapy Kits Annual Sales by Company (2021-2026)

    • 3.1.2 Global Phage Therapy Kits Sales Market Share by Company (2021-2026)

  • 3.2 Global Phage Therapy Kits Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Phage Therapy Kits Revenue by Company (2021-2026)

    • 3.2.2 Global Phage Therapy Kits Revenue Market Share by Company (2021-2026)

  • 3.3 Global Phage Therapy Kits Sale Price by Company

  • 3.4 Key Manufacturers Phage Therapy Kits Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Phage Therapy Kits Product Location Distribution

    • 3.4.2 Players Phage Therapy Kits Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Phage Therapy Kits by Geographic Region

  • 4.1 World Historic Phage Therapy Kits Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Phage Therapy Kits Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Phage Therapy Kits Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Phage Therapy Kits Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Phage Therapy Kits Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Phage Therapy Kits Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Phage Therapy Kits Sales Growth

  • 4.4 APAC Phage Therapy Kits Sales Growth

  • 4.5 Europe Phage Therapy Kits Sales Growth

  • 4.6 Middle East & Africa Phage Therapy Kits Sales Growth

• 5 Americas

  • 5.1 Americas Phage Therapy Kits Sales by Country

    • 5.1.1 Americas Phage Therapy Kits Sales by Country (2021-2026)

    • 5.1.2 Americas Phage Therapy Kits Revenue by Country (2021-2026)

  • 5.2 Americas Phage Therapy Kits Sales by Type (2021-2026)

  • 5.3 Americas Phage Therapy Kits Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Phage Therapy Kits Sales by Region

    • 6.1.1 APAC Phage Therapy Kits Sales by Region (2021-2026)

    • 6.1.2 APAC Phage Therapy Kits Revenue by Region (2021-2026)

  • 6.2 APAC Phage Therapy Kits Sales by Type (2021-2026)

  • 6.3 APAC Phage Therapy Kits Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Phage Therapy Kits by Country

    • 7.1.1 Europe Phage Therapy Kits Sales by Country (2021-2026)

    • 7.1.2 Europe Phage Therapy Kits Revenue by Country (2021-2026)

  • 7.2 Europe Phage Therapy Kits Sales by Type (2021-2026)

  • 7.3 Europe Phage Therapy Kits Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Phage Therapy Kits by Country

    • 8.1.1 Middle East & Africa Phage Therapy Kits Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Phage Therapy Kits Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Phage Therapy Kits Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Phage Therapy Kits Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Phage Therapy Kits

  • 10.3 Manufacturing Process Analysis of Phage Therapy Kits

  • 10.4 Industry Chain Structure of Phage Therapy Kits

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Phage Therapy Kits Distributors

  • 11.3 Phage Therapy Kits Customer

• 12 World Forecast Review for Phage Therapy Kits by Geographic Region

  • 12.1 Global Phage Therapy Kits Market Size Forecast by Region

    • 12.1.1 Global Phage Therapy Kits Forecast by Region (2027-2032)

    • 12.1.2 Global Phage Therapy Kits Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Phage Therapy Kits Forecast by Type (2027-2032)

  • 12.7 Global Phage Therapy Kits Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 BiomX

    • 13.1.1 BiomX Company Information

    • 13.1.2 BiomX Phage Therapy Kits Product Portfolios and Specifications

    • 13.1.3 BiomX Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 BiomX Main Business Overview

    • 13.1.5 BiomX Latest Developments

  • 13.2 PhagePro

    • 13.2.1 PhagePro Company Information

    • 13.2.2 PhagePro Phage Therapy Kits Product Portfolios and Specifications

    • 13.2.3 PhagePro Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 PhagePro Main Business Overview

    • 13.2.5 PhagePro Latest Developments

  • 13.3 PhagoMed Biopharma

    • 13.3.1 PhagoMed Biopharma Company Information

    • 13.3.2 PhagoMed Biopharma Phage Therapy Kits Product Portfolios and Specifications

    • 13.3.3 PhagoMed Biopharma Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 PhagoMed Biopharma Main Business Overview

    • 13.3.5 PhagoMed Biopharma Latest Developments

  • 13.4 MYRIADE

    • 13.4.1 MYRIADE Company Information

    • 13.4.2 MYRIADE Phage Therapy Kits Product Portfolios and Specifications

    • 13.4.3 MYRIADE Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 MYRIADE Main Business Overview

    • 13.4.5 MYRIADE Latest Developments

  • 13.5 DotBio

    • 13.5.1 DotBio Company Information

    • 13.5.2 DotBio Phage Therapy Kits Product Portfolios and Specifications

    • 13.5.3 DotBio Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 DotBio Main Business Overview

    • 13.5.5 DotBio Latest Developments

  • 13.6 Wuhan Greinon Biotechnology

    • 13.6.1 Wuhan Greinon Biotechnology Company Information

    • 13.6.2 Wuhan Greinon Biotechnology Phage Therapy Kits Product Portfolios and Specifications

    • 13.6.3 Wuhan Greinon Biotechnology Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Wuhan Greinon Biotechnology Main Business Overview

    • 13.6.5 Wuhan Greinon Biotechnology Latest Developments

  • 13.7 PhagePharm

    • 13.7.1 PhagePharm Company Information

    • 13.7.2 PhagePharm Phage Therapy Kits Product Portfolios and Specifications

    • 13.7.3 PhagePharm Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 PhagePharm Main Business Overview

    • 13.7.5 PhagePharm Latest Developments

  • 13.8 iNtRON Biotechnology

    • 13.8.1 iNtRON Biotechnology Company Information

    • 13.8.2 iNtRON Biotechnology Phage Therapy Kits Product Portfolios and Specifications

    • 13.8.3 iNtRON Biotechnology Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 iNtRON Biotechnology Main Business Overview

    • 13.8.5 iNtRON Biotechnology Latest Developments

  • 13.9 Snipr Technologies

    • 13.9.1 Snipr Technologies Company Information

    • 13.9.2 Snipr Technologies Phage Therapy Kits Product Portfolios and Specifications

    • 13.9.3 Snipr Technologies Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Snipr Technologies Main Business Overview

    • 13.9.5 Snipr Technologies Latest Developments

  • 13.10 CJ

    • 13.10.1 CJ Company Information

    • 13.10.2 CJ Phage Therapy Kits Product Portfolios and Specifications

    • 13.10.3 CJ Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 CJ Main Business Overview

    • 13.10.5 CJ Latest Developments

  • 13.11 Phico Therapeutics

    • 13.11.1 Phico Therapeutics Company Information

    • 13.11.2 Phico Therapeutics Phage Therapy Kits Product Portfolios and Specifications

    • 13.11.3 Phico Therapeutics Phage Therapy Kits Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Phico Therapeutics Main Business Overview

    • 13.11.5 Phico Therapeutics Latest Developments

• 14 Research Findings and Conclusion